Clinical trial
POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
NCT03508219 is registered in ClinicalTrials.gov with ECRI bv as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- POLish Bifurcation Optimal Treatment Strategy Study for Left Main Bifurcation Percutaneous Coronary Intervention (PCI)
- Lead sponsor
- ECRI bv
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- August 10, 2018
- Completion date
- April 15, 2021
- Enrollment
- 130 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.